Breaking News on Contract Research, Manufacturing & Clinical Trials

Headlines > Preclinical Research

News in brief

WuXi calls theft of two client compounds an “isolated case”

04-Jun-2012

WuXi PharmaTech has called the theft of two compounds by an employee an “isolated case” and said it is upping oversight.

The statement from WuXi comes after a former employee was convicted in China for stealing sample amounts of two patented chemicals the CRO (contract research organisation) produced for a client.

We regret that one of our employees committed a crime on our premises. As in any company, there will always be the risk of damage caused by a determined criminal”, Ge Li, and CEO of WuXi, said. Li said WuXi has responded by intensifying training and conducting more unannounced inspections.

The conviction comes weeks after a former Sanofi chemist was sentenced to 18 months in prison for stealing trade secrets.

Key Industry Events

Interphex 2014

New York, NY 10001 / Conference and exhibition

Read more

Access all events listing